Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report)’s share price was down 5.2% during mid-day trading on Thursday . The company traded as low as $4.33 and last traded at $4.42. Approximately 632,491 shares were traded during mid-day trading, a decline of 28% from the average daily volume of 875,832 shares. The stock had previously closed at $4.66.
Analyst Ratings Changes
A number of equities analysts have recently commented on the stock. TD Cowen started coverage on shares of Aurora Cannabis in a research report on Wednesday, December 11th. They issued a “buy” rating for the company. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th.
Check Out Our Latest Stock Report on Aurora Cannabis
Aurora Cannabis Price Performance
Institutional Trading of Aurora Cannabis
A number of hedge funds have recently made changes to their positions in the stock. Tidal Investments LLC lifted its position in Aurora Cannabis by 2.7% in the 3rd quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock worth $7,905,000 after buying an additional 34,988 shares during the last quarter. Cubist Systematic Strategies LLC bought a new stake in shares of Aurora Cannabis in the 2nd quarter worth approximately $50,000. Mackenzie Financial Corp purchased a new stake in shares of Aurora Cannabis in the 2nd quarter valued at $113,000. Toronto Dominion Bank boosted its stake in shares of Aurora Cannabis by 34,356.4% in the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock valued at $88,000 after purchasing an additional 18,896 shares in the last quarter. Finally, Headlands Technologies LLC grew its holdings in shares of Aurora Cannabis by 98.8% during the 2nd quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock valued at $346,000 after purchasing an additional 37,269 shares during the last quarter. 47.63% of the stock is owned by institutional investors.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Read More
- Five stocks we like better than Aurora Cannabis
- Comparing and Trading High PE Ratio Stocks
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- 3 Fintech Stocks With Good 2021 Prospects
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Compound Interest and Why It Matters When Investing
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.